Article PDF
References
British National Formulary. London: British Medical Association and The Royal Pharmaceutical Society of Great Britain, September 1999:469.
Toris CB, Gleason ML, Camras CB, et al. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch OphthalmoI 1995;113:1514–7.
Moorthy RS, Valluri S, Jampol LM . Drug induced uveitis. Surv Ophthalmol 1998;42:557–70.
Melles R, Wong I . Metipranolol-associated granulomatous iritis. Am J Ophthalmol 1994;118:712–5.
Fechtner RD, Khouri AS, Zimmerman TJ, et al. Anterior uveitis associated with latanoprost. Am J OphthalmoI 1998;126:37–41.
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goyal, R., Raghu Ram, A. Brimonidine tartarate 0.2% (Alphagan) associated granulomatous anterior uveitis. Eye 14, 908–910 (2000). https://doi.org/10.1038/eye.2000.250
Issue Date:
DOI: https://doi.org/10.1038/eye.2000.250
This article is cited by
-
The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
BMC Pharmacology and Toxicology (2020)
-
Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients
Journal of Ophthalmic Inflammation and Infection (2016)
-
Drug-induced uveitis
Journal of Ophthalmic Inflammation and Infection (2013)
-
Granulomatous anterior uveitis associated with 0.2% topical brimonidine
Eye (2003)